Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high …

Cerebrovascular disease involves various medical disorders that obstruct brain blood
vessels or deteriorate cerebral circulation, resulting in ischemic or hemorrhagic stroke …

Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …

BACKGROUND: Symptomatic intracranial atherosclerotic disease (sICAD) is estimated to
cause 10% of strokes annually in the United States. However, treatment remains a …

Drug-eluting stent (DES) is a potential endovascular treatment for patients with symptomatic
intracranial atherosclerotic disease (sICAD). However, evidence regarding the treatment of …

Introduction Current methods for angioplasty and stenting of the intracranial vasculature for
neurointervention are limited. The Wingspan Stent System is Food and Drug Administration …

Although there is an intuitive appeal to treat symptomatic stenotic intracranial arteries with
endovascular therapies such as angioplasty and stenting, current data from randomized …

Purpose: In the treatment of intracranial arterial stenosis (ICAS), controversies remain
regarding the optimal treatment strategy. Our study aims to conduct an individual patient …

Introduction. The initial promise of endovascular stenting for the treatment of intracranial
atherosclerotic disease (ICAD) has been tempered by the results of the SAMMPRIS trial …

Hintergrund Intrakranielle arteriosklerotische Stenosen (ICAS) sind in der europäischen
Bevölkerung ursächlich für 5–10% der zerebralen Ischämien. Die Indikationsstellung zur …